The expanding role of blood and tissue establishments in the development of advanced therapy medicinal products

This publication has 17 references indexed in Scilit:

• A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience
  Cytotherapy, 2022
• Recommendations for procurement of starting materials by apheresis for advanced therapy medicinal products
  Cytotherapy, 2022
• Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties of Mesenchymal Stromal/Stem Cells and Other Common Cellular Therapeutics
  Current Stem Cell Reports, 2022
• Cord blood and amniotic membrane extract eye drop preparations display immune-suppressive and regenerative properties
  Scientific Reports, 2021
• The wider perspective: cord blood banks and their future prospects
  British Journal of Haematology, 2021
• Influence of platelet storage time on human platelet lysates and platelet lysate-expanded mesenchymal stromal cells for bone tissue engineering
  Stem Cell Research & Therapy, 2020
• Human platelet lysate to substitute fetal bovine serum in hMSC expansion for translational applications: a systematic review
  Journal of Translational Medicine, 2020
• Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative Medicine
  Journal of Clinical Medicine Research, 2020
• Effective technology transfer in the GMP network of the Andalusian initiative for advanced therapies
  Cytotherapy, 2017
• The Cell Therapy Catapult: Growing a U.K. Cell Therapy Industry Generating Health and Wealth
  Stem Cells and Development, 2013